| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8302 |
| Human Intestinal Absorption | HIA+ | 0.9639 |
| Caco-2 Permeability | Caco2+ | 0.6312 |
| P-glycoprotein Substrate | Non-substrate | 0.6489 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8707 |
| Non-inhibitor | 0.5365 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6512 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6231 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6776 |
| CYP450 2D6 Substrate | Non-substrate | 0.7276 |
| CYP450 3A4 Substrate | Substrate | 0.5518 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5555 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7237 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.6718 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.5921 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.5790 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8446 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9625 |
| Non-inhibitor | 0.5571 |
| AMES Toxicity | AMES toxic | 0.5907 |
| Carcinogens | Carcinogens | 0.8461 |
| Fish Toxicity | High FHMT | 0.9223 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9822 |
| Honey Bee Toxicity | Low HBT | 0.7958 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6397 |
| Carcinogenicity (Three-class) | Warning | 0.4626 |